A More Desirable Balanced Polyunsaturated Fatty Acid Composition Achieved by Heterologous Expression of Δ15/Δ4 Desaturases in Mammalian Cells

Guiming Zhu, Ou Qin, Tao Zhang, Xudong Jiang, Sun Guo-zhi, Ning Zhang, Kunfu Wang, Heng Fang, Mingfu Wang, Jie Sun, Tangdong GePLoS 2013 · DOI

Abstract

Arachidonic (ARA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids are the most biologically active polyunsaturated fatty acids, but their biosyntheses in mammals are very limited. The biosynthesis of DHA is the most difficult, because this undergoes the Sprecher pathway--a further elongation step from docosapentaenoic acid (DPA), a Δ6-desaturase acting on a C24 fatty acid substrate followed by a peroxisomal chain shortening step. This paper reports the successful heterologous expression of two non-mammalian genes (with modification of codon usage), coding for Euglena gracilis Δ4-desaturase and Siganus canaliculatus Δ4-desaturase respectively, in mammalian cells (HEK293 cell line). Both of the Δ4-desaturases can efficiently function, directly converting DPA into DHA. Moreover, the cooperation of the E. gracilis Δ4-desaturase with C. elegans Δ15-desaturase (able to convert a number of n-6 PUFAs to their corresponding n-3 PUFAs) in transgenic HEK293 cells made a more desirable fatty acid composition--a drastically reduced n-6/n-3 PUFAs ratio and a high level of DHA as well as EPA and ARA. Our findings provide a basis for potential applications of the gene constructs for expression of Δ15/Δ4-desaturases in transgenic livestock to produce such a fatty acid profile in the related products, which certainly will bring benefit to human health.

Introduction

Polyunsaturated fatty acids (PUFAs), particularly Omega-3s such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are critical for cardiovascular and neurological health. However, modern diets are often imbalanced, with Omega-6 (n-6) to Omega-3 (n-3) ratios frequently exceeding 10:1, a state associated with chronic inflammation and various diseases.

Mammals face a biological bottleneck in correcting this imbalance. They lack the enzymes necessary to convert n-6 fats into n-3 fats efficiently. Furthermore, the endogenous production of DHA in mammals follows the complex Sprecher pathway. This pathway requires elongation of fatty acids to 24 carbons, Δ6-desaturation in the endoplasmic reticulum, and subsequent translocation to peroxisomes for chain shortening back to 22 carbons. This multi-step process is highly inefficient. This study explores a metabolic "shortcut" by heterologously expressing non-mammalian desaturases to bypass these limitations.

Materials and Methods

The researchers employed a heterologous expression strategy using human HEK293 cells as a model mammalian host. Key genes were selected from diverse species:

  • Δ4-desaturases: Sourced from the freshwater alga Euglena gracilis (sEgD4) and the rabbitfish Siganus canaliculatus (sScD4).
  • Δ15-desaturase: The fat-1 gene from the roundworm C. elegans (sN3).

To ensure optimal expression in mammalian cells, these non-mammalian sequences underwent codon optimization. The genes were then cloned into pcDNA3.1 expression vectors to create single and dual-gene constructs.

Schematic of the expression vectors for Δ15 and Δ4 desaturases.

As shown in the figure above, four primary constructs were developed: single-gene vectors for each Δ4-desaturase (A, B), a single-gene vector for the Δ15-desaturase (C), and a dual-gene construct (D) designed to express both Δ15 and Δ4 desaturases simultaneously. Transfected cells were supplemented with specific fatty acid substrates, and their lipid profiles were subsequently analyzed using Gas Chromatography-Mass Spectrometry (GC-MS).

Results

Bypassing the Sprecher Pathway

The introduction of Δ4-desaturases successfully created a metabolic shortcut. These enzymes directly converted DPA into DHA within the endoplasmic reticulum, effectively bypassing the peroxisomal steps of the Sprecher pathway. Cells expressing these enzymes showed a significant increase in DHA levels, with DHA/DPA ratios reaching 0.83–0.88, a nearly threefold increase over the 0.29 ratio observed in control cells.

Synergistic Effects of Dual Expression

The most striking results came from the dual-gene construct (N3D4). While the Δ15-desaturase is proficient at converting n-6 precursors to n-3 forms, it typically results in an accumulation of DPA. By co-expressing Δ4-desaturase, the researchers established a complete biosynthetic pipeline. In these cells, n-6 precursors (such as 18:2n-6 and 20:4n-6) were markedly reduced.

The overall n-6/n-3 ratio was drastically improved, dropping from 8.76 in control cells to 1.46 in the N3D4 group. Furthermore, DHA levels in the dual-gene cells were approximately double those found in cells expressing the Δ15-desaturase alone, demonstrating the high efficiency of the combined enzymatic activity.

Discussion

This study demonstrates that heterologous expression of codon-optimized Δ15 and Δ4 desaturases can fundamentally reshape the fatty acid profile of mammalian cells. The efficiency of these enzymes in HEK293 cells (converting ~37% of substrate) surpassed previous benchmarks in yeast models, suggesting that mammalian cellular environments are highly conducive to this engineered pathway.

While these results are promising, they represent an in vitro proof-of-concept. The ultimate goal is the development of transgenic livestock, such as pigs or cattle, capable of producing meat and milk naturally enriched with Omega-3 fatty acids. Such "designer" animal products could provide a sustainable and accessible means of improving human nutritional health. Future research must address the transition to in vivo models and ensure the safety and regulatory compliance of transgenic food products.

Summary updated

Abstract

Arachidonic (ARA), eicosapentaenoic (EPA) and docosahexaenoic (DHA) acids are the most biologically active polyunsaturated fatty acids, but their biosyntheses in mammals are very limited. The biosynthesis of DHA is the most difficult, because this undergoes the Sprecher pathway--a further elongation step from docosapentaenoic acid (DPA), a Δ6-desaturase acting on a C24 fatty acid substrate followed by a peroxisomal chain shortening step. This paper reports the successful heterologous expression of two non-mammalian genes (with modification of codon usage), coding for Euglena gracilis Δ4-desaturase and Siganus canaliculatus Δ4-desaturase respectively, in mammalian cells (HEK293 cell line). Both of the Δ4-desaturases can efficiently function, directly converting DPA into DHA. Moreover, the cooperation of the E. gracilis Δ4-desaturase with C. elegans Δ15-desaturase (able to convert a number of n-6 PUFAs to their corresponding n-3 PUFAs) in transgenic HEK293 cells made a more desirable fatty acid composition--a drastically reduced n-6/n-3 PUFAs ratio and a high level of DHA as well as EPA and ARA. Our findings provide a basis for potential applications of the gene constructs for expression of Δ15/Δ4-desaturases in transgenic livestock to produce such a fatty acid profile in the related products, which certainly will bring benefit to human health.
BibTeX
@inproceedings{zhu2013more,
  author = {Guiming Zhu and Ou Qin and Tao Zhang and Xudong Jiang and Sun Guo-zhi and Ning Zhang and Kunfu Wang and Heng Fang and Mingfu Wang and Jie Sun and Tangdong Ge},
  title = {{A More Desirable Balanced Polyunsaturated Fatty Acid Composition Achieved by Heterologous Expression of Δ15/Δ4 Desaturases in Mammalian Cells}},
  booktitle = {PLoS},
  year = {2013},
  doi = {10.1371/journal.pone.0084871},
}
Figure